Table 2.
Oligo-nucleotide primers for the viral amplification
| Amplification | Primers | HXB2 Coordinate | Sequence (5'-3') |
| N-term 3.0 kb fragment | |||
| First round | N558F | 0001 | TGGAAGGGTTAATTTACTCTAAGGAAAGGCAAGAGATCCTTG |
| N453R | 4820 | CTATTATGTCTACTATTCTTTCCCCTGCAC | |
| Second round | N533F | 0001 | GGGGGGCAGTGCGGCCGCTGGAAGGGTTAATTTACTCYMAGAAAAGRCAAG |
| N502R | 2878 | TGAAAAATACGCGTCMCCCACATCCAGTACTGT | |
| C-term 6.5 kb fragment | |||
| First round | N501F | 1851 | CCAYAAAGCACGCGTKTTGGCTGARGCAATGAG |
| N476R | 9719 | TGCTAGAGATTTTCCACACTGACTAAAAGGGTCTGAGGTCTCTAGTT | |
| Second round | N503F | 2841 | ACTGGATGTGGGKGACGCGTATTTTTCAGTTCC |
| N600R | 9719 | GCTTCGCATCCTGCAGGTGCTAGAGATTTTCCACACTGACTAAAAGGGTC | |
Sequences of the reverse oligo-nucleotides have been presented as inverse complement. Restriction enzyme sites have been underlined.